Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells - PubMed (original) (raw)
Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells
S Klein et al. Mol Biol Cell. 1993 Oct.
Free PMC article
Abstract
During angiogenesis capillary endothelial cells undergo a coordinated set of modifications in their interactions with extracellular matrix components. In this study we have investigated the effect of the prototypical angiogenic factor basic fibroblast growth factor (bFGF) on the expression and function of several integrins in microvascular endothelial cells. Immunoprecipitation experiments with antibodies to individual subunits indicated that microvascular cells express at their surface several integrins. These include the alpha 1 beta 1, alpha 2 beta 1, and alpha 3 beta 1 laminin/collagen receptors; the alpha 6 beta 1 laminin receptor; the alpha 5 beta 1 and alpha v beta 1 fibronectin receptors; the alpha 6 beta 4 basement membrane receptor; and the alpha v beta 3 and alpha v beta 5 vitronectin receptors. Treatment with bFGF caused a significant increase in the surface expression of the alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1, alpha 6 beta 1, alpha 6 beta 4, and alpha v beta 5 integrins. In contrast, the level of expression of the alpha 1 beta 1 and alpha v beta 3 integrins was decreased in bFGF-treated cells. Immunoprecipitation of metabolically labeled cells indicated that bFGF increases the biosynthesis of the alpha 3, alpha 5, alpha 6, beta 4, and beta 5 subunits and decreases the production of the alpha v and beta 3 subunits. These results suggest that bFGF modulates integrin expression by altering the biosynthesis of individual alpha or beta subunits. In accordance with the upregulation of several integrins observed in bFGF-treated cells, these cells adhered better to fibronectin, laminin, vitronectin, and type I collagen than did untreated cells. The largest differences in beta 1 integrin expression occurred approximately 72 h after exposure to bFGF, at a time when the expression of the endothelial cell-to-cell adhesion molecule endoCAM was also significantly upregulated. In contrast, a shorter exposure to bFGF (24-48 h) was required for the maximal induction of plasminogen activator production in the same cells. Taken together, these results show that bFGF causes significant changes in the level of expression and function of several integrins in microvascular endothelial cells.
Similar articles
- Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells.
Enenstein J, Waleh NS, Kramer RH. Enenstein J, et al. Exp Cell Res. 1992 Dec;203(2):499-503. doi: 10.1016/0014-4827(92)90028-7. Exp Cell Res. 1992. PMID: 1459210 - Effect of growth factors on expression of integrin subtypes in microvascular endothelial cells isolated from bovine retinas.
Enaida H, Ito T, Oshima Y, Sakamoto T, Yago K, Kato K, Kochi H. Enaida H, et al. Fukushima J Med Sci. 1998 Jun;44(1):43-52. Fukushima J Med Sci. 1998. PMID: 9775530 - Cytokines modulate integrin alpha(v)beta(3)-mediated human endothelial cell adhesion and calcium signaling.
Yeh CH, Peng HC, Huang TF. Yeh CH, et al. Exp Cell Res. 1999 Aug 25;251(1):57-66. doi: 10.1006/excr.1999.4560. Exp Cell Res. 1999. PMID: 10438571 - Growth factor control of extracellular proteolysis.
Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P. Rifkin DB, et al. Cell Differ Dev. 1990 Dec 2;32(3):313-8. doi: 10.1016/0922-3371(90)90045-x. Cell Differ Dev. 1990. PMID: 1711916 Review. - Integrins in human cells and tumors.
Virtanen I, Korhonen M, Kariniemi AL, Gould VE, Laitinen L, Ylänne J. Virtanen I, et al. Cell Differ Dev. 1990 Dec 2;32(3):215-27. doi: 10.1016/0922-3371(90)90034-t. Cell Differ Dev. 1990. PMID: 2099238 Review.
Cited by
- Role of Herbal Extracts of Catechu from Uncaria gambir in the Treatment of Chronic Diabetic Wounds.
Ho TJ, Tsai PH, Hsieh CH, Lin JH, Lin YW, Wu JR, Chen HP. Ho TJ, et al. Pharmaceuticals (Basel). 2022 Dec 31;16(1):66. doi: 10.3390/ph16010066. Pharmaceuticals (Basel). 2022. PMID: 36678562 Free PMC article. - Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen.
Sainz IM, Isordia-Salas I, Espinola RG, Long WK, Pixley RA, Colman RW. Sainz IM, et al. Cancer Immunol Immunother. 2006 Jul;55(7):797-807. doi: 10.1007/s00262-005-0068-8. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187087 Free PMC article. - Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC.
Ballas MS, Chachoua A. Ballas MS, et al. Onco Targets Ther. 2011;4:43-58. doi: 10.2147/OTT.S18155. Epub 2011 May 30. Onco Targets Ther. 2011. PMID: 21691577 Free PMC article. - Angiogenic potential of microvessel fragments established in three-dimensional collagen gels.
Hoying JB, Boswell CA, Williams SK. Hoying JB, et al. In Vitro Cell Dev Biol Anim. 1996 Jul-Aug;32(7):409-19. doi: 10.1007/BF02723003. In Vitro Cell Dev Biol Anim. 1996. PMID: 8856341 - Angiogenesis: Biological Mechanisms and In Vitro Models.
Brunmaier LAE, Ozdemir T, Walker TW. Brunmaier LAE, et al. Ann Biomed Eng. 2025 Jul;53(7):1543-1574. doi: 10.1007/s10439-025-03721-2. Epub 2025 Apr 10. Ann Biomed Eng. 2025. PMID: 40210793 Review.
References
- J Cell Biol. 1991 Aug;114(4):855-63 - PubMed
- Proc Natl Acad Sci U S A. 1979 Oct;76(10):5217-21 - PubMed
- J Cell Biol. 1992 Jan;116(2):477-87 - PubMed
- Cell. 1992 Mar 20;68(6):1051-60 - PubMed
- Cell. 1992 Apr 3;69(1):11-25 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources